Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The S&P500 closed in the red on Friday, after the week saw a massive sell-off of AI-related stocks sparked by worries around ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

As bird flu continues to threaten animals and public health, the U.S. government has stepped up its response. Experts says it ...

Mexico’s first female president On October 1, Claudia Sheinbaum became Mexico’s first female and Jewish president, making history. In a nation where women were granted the right to vote only in 1953, ...

“Successful self-replication under no human assistance is the essential step for AI to outsmart [humans], and is an early ...